ALTEROME THERAPEUTICS
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.
ALTEROME THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.alterome.com
Total Employee:
11+
Status:
Active
Contact:
650-493-9300
Total Funding:
231 M USD
Technology used in webpage:
Google Google Cloud Microsoft Microsoft Azure Microsoft Azure US West Region Bamboo HR
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Enalare Therapeutics
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Paracrine
Paracrine is a biopharmaceutical company provided development of stem exosome for regenerative medicine.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Alterome Therapeutics
Goldman Sachs
Goldman Sachs investment in Series B - Alterome Therapeutics
Boxer Capital
Boxer Capital investment in Series B - Alterome Therapeutics
Colt Ventures
Colt Ventures investment in Series B - Alterome Therapeutics
Digitalis Ventures
Digitalis Ventures investment in Series B - Alterome Therapeutics
Invus
Invus investment in Series B - Alterome Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Alterome Therapeutics
Blue Owl
Blue Owl investment in Series B - Alterome Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Alterome Therapeutics
Canaan Partners
Canaan Partners investment in Series B - Alterome Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2023-08-23 | Alterome Therapeutics Welcomes Andrew S. Chi, M.D., Ph.D., as Chief Medical Officer |
Official Site Inspections
http://www.alterome.com
- Host name: 132.89.139.34.bc.googleusercontent.com
- IP address: 34.139.89.132
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alterome Therapeutics"
Who We Are - Alterome
Alterome is dedicated to relentlessly pushing the boundaries of cancer treatments to transform the lives of patients.See details»
Alterome Therapeutics - Crunchbase Company Profile …
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies. View contacts for Alterome Therapeutics to access new leads and connect with decision-makers.See details»
What We Do - Alterome
The alterome, consisting of all the disease driving alterations in genes, remains largely undrugged. It has long been known that genetic alterations are oncogenic drivers. Several targeted therapies have provided benefit to patients. …See details»
Alterome Therapeutics, Inc | LinkedIn
Alterome Therapeutics, Inc | 2,990 followers on LinkedIn. To Life! | Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value ...See details»
Alterome Therapeutics Company Profile 2024: Valuation, Funding ...
Alterome Therapeutics General Information Description. Developer precision oncology therapeutics designed for targeting oncogenic drivers. The company's therapeutics utilizes …See details»
Alterome Therapeutics, Inc - Org Chart, Teams, Culture & Jobs
View Alterome Therapeutics, Inc's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to …
SAN DIEGO, October 17, 2024--Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the …See details»
Alterome Therapeutics - Updates, News, Events, Signals & Triggers
Alterome Therapeutics secured a $132 million Series B financing led by Goldman Sachs to advance its pipeline of next-generation, small-molecule targeted therapies for cancer. This …See details»
Alterome Therapeutics Raises $132 Million in Series B Financing …
SAN DIEGO, April 03, 2024--Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the …See details»
Alterome Therapeutics - Funding, Financials, Valuation & Investors
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to …
Oct 17, 2024 “ Alterome has moved our two lead programs from concept to clinic in less than 3 years, raising $231 million from a world-class investor syndicate to support clinical testing of …See details»
Org Chart Alterome Therapeutics - The Official Board
Organizational Chart of Alterome Therapeutics. Alterome Therapeutics www.alterome.com. has 26 executives +1 212 739 6400; Add an executive. Alterome Therapeutics News . Anything …See details»
Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to …
Oct 17, 2024 SAN DIEGO--(BUSINESS WIRE)--Oct. 17, 2024-- Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule …See details»
Alterome Therapeutics - Contacts, Employees, Board Members
Organization. Alterome Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Alterome Therapeutics has 3 current …See details»
Alterome raises $132M to release ‘the Kraken’ on cancer-driving …
Apr 3, 2024 Alterome’s lead programme targets AKT1 E17K, a clinically validated oncogene that drives about 2% of all tumours, including breast, endometrial and prostate cancers. The oral …See details»
Join Us - Alterome
Alterome Therapeutics, Inc. is an equal opportunity employer committed to building a diverse and inclusive organization. We measure each applicant, candidate and employee based on their …See details»
Programs - Alterome
Portfolio of Validated Oncogenic Drivers with Clear Paths to Early Clinical Signals Our deep expertise in small molecule, structure-guided oncology drug discovery enables us to develop …See details»
Alterome in the News Archives - Alterome
Jan 25, 2023 Alterome raises $132M to take next-gen cancer drugs aimed at the ‘undruggable’ into clinic With a new $132 million in hand, Alterome Therapeutics is finally divulging what it’s …See details»
Press Releases Archives - Alterome
Jan 5, 2023 Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, …See details»